Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4790653
Max Phase: Preclinical
Molecular Formula: C24H25N3O4
Molecular Weight: 419.48
Molecule Type: Unknown
Associated Items:
ID: ALA4790653
Max Phase: Preclinical
Molecular Formula: C24H25N3O4
Molecular Weight: 419.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(C(=O)NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O)c1ccccc1
Standard InChI: InChI=1S/C24H25N3O4/c1-24(2,17-6-4-3-5-7-17)23(31)25-13-15-8-9-18-16(12-15)14-27(22(18)30)19-10-11-20(28)26-21(19)29/h3-9,12,19H,10-11,13-14H2,1-2H3,(H,25,31)(H,26,28,29)
Standard InChI Key: NOJKJVONTQZKHX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 419.48 | Molecular Weight (Monoisotopic): 419.1845 | AlogP: 2.04 | #Rotatable Bonds: 5 |
Polar Surface Area: 95.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.61 | CX Basic pKa: | CX LogP: 2.00 | CX LogD: 2.00 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.73 | Np Likeness Score: -0.42 |
1. Hansen JD,Correa M,Alexander M,Nagy M,Huang D,Sapienza J,Lu G,LeBrun LA,Cathers BE,Zhang W,Tang Y,Ammirante M,Narla RK,Piccotti JR,Pourdehnad M,Lopez-Girona A. (2021) CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia., 64 (4.0): [PMID:33591756] [10.1021/acs.jmedchem.0c01489] |
Source(1):